Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

Eledon leading a paradigm shift in immunosuppression therapy in organ transplantation

Key Takeaway: Eledon is leading a significant shift in immunosuppression therapy for organ transplantation. The company focuses on innovative solutions that aim to improve patient outcomes and transform lives. Their commitment to advancing clinical trials and sharing patient stories underscores the impact of their therapies in the field.
Price reaction · baseline $3.115 (2025-05-29T17:35:00.000Z) · hit during market hours · clean, no other ELDN news in the window
day 0 close · peak
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Eledon is pioneering new approaches in immunosuppression therapy.
  • The company aims to transform organ transplantation outcomes.
  • Patient stories highlight the positive impact of their therapies.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Transforming Lives. One Organ at a Time.
• Overview Focus Patient Stories Clinical Trials In The News
• Science Mechanism of Action Pipeline Publications & Presentations In The News
• Team Overview Leadership Board of Directors
• Investors Overview News & Events Press Releases Events Publications & Presentations Corporate Governance Governance Overview Committee Composition Ethics Hotline Financials SEC Filings Stock Information Stock Quote & Chart Analyst Coverage Resources Investor FAQs Email Alerts Contact IR
• Culture/Careers Culture Careers
• Contact
• Focus
• Patient Stories
• Clinical Trials
• In The News
• Mechanism of Action
• Pipeline
• Publications & Presentations
• In The News
• Overview
• Leadership
• Board of Directors
• Overview
• News & Events Press Releases Events Publications & Presentations
• Corporate Governance Governance Overview Committee Composition Ethics Hotline
• Financials SEC Filings
• Stock Information Stock Quote & Chart Analyst Coverage
• Resources Investor FAQs Email Alerts Contact IR
• Press Releases
• Events
• Publications & Presentations
• Governance Overview
• Committee Composition
• Ethics Hotline
• SEC Filings
• Stock Quote & Chart
• Analyst Coverage
• Investor FAQs
• Email Alerts
• Contact IR
• Culture
• Careers
• Privacy Overview
• Necessary
• Analytics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What is Eledon's focus in organ transplantation?

Eledon focuses on pioneering immunosuppression therapy to improve organ transplantation outcomes.

How does Eledon impact patient lives?

Eledon's therapies aim to transform lives by enhancing the success of organ transplants.

What role do clinical trials play for Eledon?

Clinical trials are essential for Eledon to validate their innovative approaches in therapy.

What stories highlight Eledon's impact?

Patient stories shared by Eledon showcase the positive effects of their therapies on lives.

Last updated: May 29, 2025